Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000, C544S279000, C514S264100
Reexamination Certificate
active
07968557
ABSTRACT:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the FAK, Abl, BCR-Abl, PDGF-R, c-Kit, NPM-ALK, Flt-3, JAK2 and c-Met kinases.
REFERENCES:
patent: 2004/0224964 (2004-11-01), O'Yang et al.
patent: 194820 (1967-04-01), None
patent: WO03/074530 (2003-09-01), None
patent: WO2005/107760 (2005-11-01), None
patent: WO2006/074985 (2006-07-01), None
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Vippagunta, S.R., “Advanced Drug Delivery Reviews,” 2001, 48, pp. 3-26.
Ha-Soon Choi et al., Design and Synthesis of 7H-Pyrrolo[2,3-d]pyrimidines as Focal Adhesion Kinase Inhibitors. Part 1, Bioorganic & Medical Chemistry Letters, Feb. 3, 2006, 2173-2176, Elsevier Ltd.
Ha-Soon Choi et al., Design and Synthesis of 7H-Pyrrolo[2,3-d]pyrimidines as Focal Adhesion Kinase Inhibitors. Part 2, Bioorganic & Medical Chemistry Letters, Mar. 9, 2006, 2689-2692, Elsevier Ltd.
Yakhontov et al; “Azaindole Derivatives XXVI. The Formation of 5,7-diazaindoline derivatives by the reaction of 4-chloro-5-(beta-chloroethyl)pyrimidines with secondary amines”; Khimiya Geterotsiklicheskikh Soedinenii 1:145-148 (1969)—English translation of abstract and partial experimentals provided.
Choi Ha-Soon
Gray Nathanael Schiander
Gu Xiang-ju
He Xiaohui
He Yun
Moore Susanna
Novartis AG
Novartis AG
Reid Scott W.
LandOfFree
Substituted pyrrolo[2,3-2]pyrimidines as protein kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolo[2,3-2]pyrimidines as protein kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolo[2,3-2]pyrimidines as protein kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671488